top of page
  • Rick

Lidocain HCL Topical 4% Recall-Again

Updated: Dec 14, 2021

As of October 12, 2021, Teligent Pharma is voluntarily recalling 5 lots of Lidocaine HCL 4% Topical Solution, 50 mL due to super potency.

If used, the product would result in a higher than expected dose being administered. For full information on affected lot numbers and related information, see Teligent's announcement on the FDA's recalls and safety alerts.

If you have any affected product, reach out to your dealer or Teligent Pharma for further information and instructions.

As of December 4th there has been another recall for the same reason.


Recent Posts

See All

FDA Recall of certain Monoject Syringes

Cardinal Health has announced a recall of certain sizes of their Monoject leur-lock syringes. in concert with the FDA, they have issued a safety communication to remove the following sizes of Cardinal


bottom of page